Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People’s Republic of China and in...
Hangzhou Tigermed Consulting Co., Ltd. Class H (5HZ1) Receives a Buy from Citi
UBS: CN CRO Sees Solid Revenue Growth in 1H; WUXI APPTEC Top Pick
UBS' Investment Ratings and TPs on CRO Stocks (Table)
Daiwa Raises TIGERMED to Buy, Cuts TP to HKD44
Hangzhou Tigermed files HKEX next-day disclosure reporting share repurchase
Hangzhou Tigermed files HKEX next-day disclosure return on share buyback cancellation